EUVIMEDEUVIMED entdecken
Crossref

Outcomes in early vs. Late liver retransplantation – a 10-year single centre analysis

C. van Beekum, D. Kleine-Döpke, H. Zlatev, M. Quante, N. Richter, M. Schmelzle, P. Felgendreff

Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e694-e695

DOI: 10.1055/s-0044-1789846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von C. van Beekum und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Re-transplantation is the only form of treatment for patients with irreversible graft failure after liver transplantation (LT). In the early stages following LT, primary nonfunction or vascular thrombosis are the leading indications for liver re-transplantation (ReLT). In contrast, more and more patients with end-stage liver graft disease years after the initial LT present in clinical practice. However, the ReLT indication criteria for this group of patients are variable and part of current discussions. Therefore, this study systematically compares the indication and outcome of patients following ReLT in early vs. late ReLT.

Methods

Retrospective data analysis identified 693 LTs at Hannover Medical School from January 1st, 2008, to December 31st, 2017. All patients receiving a single LT were excluded from further analysis. The remaining patients receiving a ReLT were divided into two cohorts, depending on the duration from the primary LT to ReLT. Group 1 included patients receiving ReLT within 365 days after primary LT. Patients with ReLT following more than 365 days after primary LT were included in group 2. The analysis of both groups included patient, donor, and graft-specific characteristics.

Results

Of the 693 patients undergoing LT, 72 patients who received ReLT were included in the analysis. The average time to ReLT of these 72 patients was 364.65 days. Fifty-six patients were included in group 1, receiving the ReLT shortly after the initial LT. Leading causes for ReLT were primary nonfunction (n=29), extensive hepatocyte necrosis in the graft (n=11), and vascular complications (n=16). Group 2 comprised 16 patients. The leading cause of ReLT in group 2 was cirrhosis of the graft and recurrence of the primary disease. The mean survival following ReLT in all patients was 364.92 days. The leading cause of death was sepsis (group 1: 13 patients; group 2: 2 patients) and cardiopulmonary complications (group 1: 6 patients; group 2: 1 patient).

Discussion

The ReLT of patients, even long-term after initial LT, represents a suitable treatment option for selected patients. However, this approach is associated with increased morbidity and reduced postoperative survival. In light of organ shortage and increased morbidity of candidates listed for ReLT, further analysis is needed to identify optimal selection criteria. Publication History Article published online: 26 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Beekum, C. V., Kleine-Döpke, D., Zlatev, H., Quante, M., Richter, N., Schmelzle, M., & Felgendreff, P. (2024). Outcomes in early vs. Late liver retransplantation – a 10-year single centre analysis. Zeitschrift für Gastroenterologie, 62(09), e694-e695. https://doi.org/10.1055/s-0044-1789846

Vancouver

Beekum CV, Kleine-Döpke D, Zlatev H, Quante M, Richter N, Schmelzle M, et al. Outcomes in early vs. Late liver retransplantation – a 10-year single centre analysis. Zeitschrift für Gastroenterologie. 2024;62(09):e694-e695. doi:10.1055/s-0044-1789846

BibTeX
@article{Beekum2024,
  author = {Beekum, C. van and Kleine-Döpke, D. and Zlatev, H. and Quante, M. and Richter, N. and Schmelzle, M. and Felgendreff, P.},
  title = {Outcomes in early vs. Late liver retransplantation – a 10-year single centre analysis},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {09},
  pages = {e694--e695},
  doi = {10.1055/s-0044-1789846}
}
Kostenlos starten →